Prostate cancer is rapidly emerging as a significant health challenge in China, with the incidence rate steadily rising. A group of distinguished Chinese experts has recently developed a comprehensive consensus aimed at addressing critical gaps in prostate cancer management, particularly in areas where high-level evidence is currently lacking. This consensus is designed to guide clinical practice, from screening to treatment and follow-up, offering a standardized approach to improve patient outcomes across the country.